I know it’s not the be-all-end-all, but it’s nice to see that ChatGPT agrees that Cynata cells wouldn’t be considered same drug as MSB cells, and therefore not bound by the exclusivity restrictions (due to product origin and manufacturing process).
I know it’s not the be-all-end-all, but it’s nice to see that...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.010(5.56%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $21.40K | 127.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 425750 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 90178 | 3 |
View Market Depth
| Last trade - 14.06pm 13/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |